Marker Expression in Pediatric Patients With Immune Thrombocytopenic Purpura Receiving Second Line Therapy.

Response to the treatment will be assessed according to The International Working Group criteria which defines Response as platelet count ≥ 30 x 10 /L and 2-fold increase in platelet count from baseline and absence of bleeding, measured on 2 occasions greater than 7 days apart. [Extracted from the article]